Mesoblast Ltd. | Ownership
Companies that own Mesoblast Ltd.
M&G Investment Management Ltd.
61,633,681
12.77%
-2,545
0.12%
06/30/2018
Capital Research & Management Co. (Global Investors)
40,327,080
8.36%
-180,074
0.01%
03/07/2018
Thorney Investment Group Australia Pty Ltd.
24,946,294
5.17%
0
6.6%
06/30/2018
Capital Research & Management Co. (World Investors)
11,435,497
2.37%
0
0%
06/30/2018
The Vanguard Group, Inc.
9,552,634
1.98%
140,760
0%
07/31/2018
Banca Credinvest SA (Investment Management)
6,093,000
1.26%
0
4.58%
07/26/2018
Foord Asset Management Pty Ltd.
5,127,840
1.06%
2,293,371
0.13%
12/31/2017
Manulife Asset Management (Hong Kong) Ltd.
2,993,187
0.62%
761,419
0.08%
12/31/2017
Vanguard Investments Australia Ltd.
2,826,818
0.59%
16,730
0.01%
07/31/2018
Baillie Gifford & Co.
2,553,003
0.53%
-802,483
0%
06/30/2018
| Address |
55 Collins Street
Melbourne Victoria (VIC) 3000
Australia
|
|
Employees
|
- |
| Website |
http://www.mesoblast.com |
| Updated |
07/08/2019 |
| Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. |
